269 related articles for article (PubMed ID: 10799855)
1. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
[TBL] [Abstract][Full Text] [Related]
4. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
5. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.
Tomasec P; Braud VM; Rickards C; Powell MB; McSharry BP; Gadola S; Cerundolo V; Borysiewicz LK; McMichael AJ; Wilkinson GW
Science; 2000 Feb; 287(5455):1031. PubMed ID: 10669413
[TBL] [Abstract][Full Text] [Related]
6. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.
Prod'homme V; Tomasec P; Cunningham C; Lemberg MK; Stanton RJ; McSharry BP; Wang EC; Cuff S; Martoglio B; Davison AJ; Braud VM; Wilkinson GW
J Immunol; 2012 Mar; 188(6):2794-804. PubMed ID: 22345649
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
9. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.
Falk CS; Mach M; Schendel DJ; Weiss EH; Hilgert I; Hahn G
J Immunol; 2002 Sep; 169(6):3257-66. PubMed ID: 12218145
[TBL] [Abstract][Full Text] [Related]
10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
11. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
12. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis.
Wooden SL; Kalb SR; Cotter RJ; Soloski MJ
J Immunol; 2005 Aug; 175(3):1383-7. PubMed ID: 16034073
[TBL] [Abstract][Full Text] [Related]
14. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
15. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW
Proc Natl Acad Sci U S A; 2002 May; 99(11):7570-5. PubMed ID: 12032324
[TBL] [Abstract][Full Text] [Related]
16. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
17. The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
Sullivan LC; Westall GP; Widjaja JM; Mifsud NA; Nguyen TH; Meehan AC; Kotsimbos TC; Brooks AG
PLoS One; 2015; 10(8):e0135972. PubMed ID: 26302084
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?
Gong F; Song S; Lv G; Pan Y; Zhang D; Jiang H
Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):551-4. PubMed ID: 22576308
[TBL] [Abstract][Full Text] [Related]
19. Human T cell receptor-mediated recognition of HLA-E.
García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
[TBL] [Abstract][Full Text] [Related]
20. Viral evasion of natural killer cells during human cytomegalovirus infection.
Braud VM; Tomasec P; Wilkinson GW
Curr Top Microbiol Immunol; 2002; 269():117-29. PubMed ID: 12224505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
